Building on our recent findings that astrocytic activation and glutamate dysregulation drive MN death in late-onset SMA [16,17], Cx43 emerges as a promising candidate mechanism for contributing to astrocyte-mediated neurotoxicity. Here, GJA1 is linked to proximal spinal muscular atrophy.